Boston Scientific Earns FDA Approval For Ranger Peripheral DCB
Executive Summary
The approval of the Ranger paclitaxel-coated balloon makes Boston Scientific the only company offering both a drug-eluting stent and drug-coated balloon for treating peripheral artery disease in the US.